Alternatives to 2027 Thomas R. Pickering Foreign Affairs Fellowship Program Administration Grant

Recruitment of Education and Research Specialist to support the Learning and Evidence Agenda for Regional Collaboration in Eastern and Southern Africa (LEARN-ESA) (P516274)

SELECTION OF CONSULTANT FIRMS FOR POST-CONTRACT SERVICES FOR THE CONSTRUCTION OF NEW SCHOOLS, UPGRADE AND REHABILITATION OF EXISTING SCHOOLS

The selection of Digital Transformation Senior Coordinator

The Selection of Technical and Vocational Education and Training (TVET) Senior Coordinator

Rehabilitation of Shelters (Public Schools) Batch 5: Lot 1 (Jezzine and Chouf), Lot 2 (West Bekaa, Zahle and Rashaya) and Lot 3 (Saida and Hasbaya)

Background & Goal: The U.S. Department of State, Bureau of Human Resources, Outreach, Fellowships, and Internships Division (HR/OFI) announces an open competition for an eligible organization to manage programmatic, financial, and administrative operations—excluding recruitment and candidate selection—for the 2027 Charles B. Rangel International Affairs Graduate Fellowship Program. Authorized pursuant to 22 U.S.C. 2719 and 22 U.S.C. 3901 et seq., this 32-month Cooperative Agreement (February 2027 – September 2029) aims to cultivate premier graduate talent for long-term careers as Foreign Service Officers in the U.S. Department of State. Problem Statement: Preparing top-tier foreign policy talent requires rigorous, continuous operational oversight across a complex two-year fellowship footprint. Without dedicated administrative management and strict fiscal oversight, Fellows face operational, financial, and logistical friction that can disrupt graduate study, delay clearance processing, and compromise timely commissioning. A specialized partner is essential to coordinate tuition disbursements, stipend management, summer internships (Capitol Hill and overseas diplomatic posts), housing, emergency medical coverage, and clearance tracking. Key Objectives & Outcomes: Financial & Academic Oversight: Execute a compliant tracking system to ensure 100% on-time disbursements for tuition ($55k/yr cap), living stipends ($33k/yr cap), and summer allowances ($11k/summer cap) under 2 CFR 200 guidelines, ensuring Fellows maintain a minimum 3.2 GPA. Clearance & Onboarding Support: Guide 100% of the cohort through mandatory testing protocols (FSOT/FSOA) and Top Secret security, medical, and suitability clearance milestones prior to graduate program completion. Internships & Mentorship: Manage Capitol Hill domestic internships, National Defense University seminars, overseas embassy placements, and structured Foreign Service mentorship.

This funding opportunity announcement (FOA) encourages applications for institutional research career development (K12) programs that propose to support intensive supervised research training and career development experiences for clinician scientists (Scholars) leading to research independence in the area of substance use and substance use disorder research.

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to stimulate translation of scientific discoveries and engineering developments in imaging, data science and/or spectroscopic technologies into methods or tools that address contemporary problems in understanding the fundamental biology, potential risk of development, diagnosis, treatment, and/or disease status for cancer or other disease.

Through this Notice of Funding Opportunity, the National Cancer Institute (NCI) seeks research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research mission of DCTD and OHAM. The proposed project must involve at least 1 clinical trial related to the scientific interests of one or more of the following research programs: Cancer Therapy Evaluation Program, Cancer Imaging Program, Cancer Diagnosis Program, Radiation Research Program, Complementary and Alternative Medicine Program and/or the HIV and AIDS Malignancies Research Programs. Applicants may propose to conduct an early phase trial by itself, or in combination with another research aim(s) as appropriate.

Awarded activities will facilitate the translation of novel recording and modulation technologies that can be used to treat and/or diagnose central nervous system (CNS) diseases and disorders and to better understand the human CNS, from proof of concept up to the stage of readiness for first in human (FIH) studies. Technologies may incorporate any signal modality (e.g., electrical, optical, magnetic, acoustic) or a combination thereof. Diverse team-based applications that integrate appropriate domains of expertise are encouraged.

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating Institutes encourages submission of applications proposing to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim to elucidate cancer risk and related outcomes (e.g., risk prediction or reduction, survival, or response to treatment, etc.). The goal of this initiative is to address key scientific questions relevant to cancer by supporting the analysis of existing clinical, environmental, surveillance, health services, vital statistics, behavioral, lifestyle, genomic, and molecular profiles data. Applicants are encouraged to leverage and perform innovative analyses of the existing data. Applications may include new research aims that are being addressed with existing data, new or advanced methods of analyses, or novel combinations and integration of datasets that allow the exploration of important scientific questions in cancer research.

This funding opportunity is part of a suite of NOFOs within the NIH HEAL Initiative to support the development of safe, effective, and non-addictive therapeutics to treat pain. The goal is to encourage initial translational efforts that will support a drug discovery program and advance projects to the point where they meet the entry criteria for the Pain Therapeutics Development Program. The scope will therefore be focused on development of assays to support a distinct testing funnel, screening efforts to identify hits, and initial characterization of hits and potential therapeutic agents (including small molecules, biologics, and natural products).